HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Traditional Chinese Medicine

895.512

+2.0560.23%

Number of Gainers:7

Number of Losers:3

Number of Flat:1

PE:- -

High:903.416

Open:893.004

Low:891.969

Close:893.455

Volume:38.38M

Turnover:139.42M

Market Cap:93.37B

Float Cap:63.34B

Loading ...

AK Medical Holdings Wins Multiple Hospital Equipment Tenders in China

Modern Chinese Medicine Group Delays Circular Despatch to April 2026

Xiao Yaoxi Appointed as Independent Non-Executive Director at Tong Ren Tang Technologies

Tong Ren Tang Technologies Files Director List to HKEX

Tong Ren Tang Technologies Co. Ltd. Held Extraordinary General Meeting

Eight Government Bodies Issue Plan to Boost Traditional Chinese Medicine Industry Development

JPMorgan Boosts Stake in Baiyunshan by 360,600 Shares at HK$18.85 Each

Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules

MT Newswires Live

Baiyunshan (00874): Subsidiary's Pharmaceutical Production License Amended

China Traditional Chinese Medicine Holdings Co. Limited Held Extraordinary General Meeting

JBM Healthcare CEO to Step Down; Successor Appointed

MT Newswires Live

Consun Pharmaceutical Group (SEHK:1681) Valuation Check After Expanded HK$300 Million Share Buyback Plan

Simply Wall St.

JBM HEALTHCARE (02161): Cen Guangye to be Appointed as New CEO

JBM (Healthcare) Ltd. Appoints Sum Kwong Yip as New CEO

JBM (Healthcare) Ltd - Wong Yat Wai, Patrick Resign as CEO

THOMSON REUTERS

CONSUN PHARMA (01681) Proposes to Repurchase Up to HK$300 Million in Company Shares

Consun Pharma Expands Share Buyback Program to HK$300 Million

MT Newswires Live

Consun Pharmaceutical - Implement Another Share Repurchase Program Increased up to Further HKD100 Mln

THOMSON REUTERS

Morgan Stanley Cuts TRAD CHI MED (00570) Target Price to HK$1.4, Maintains "Underweight" Rating

China Traditional Chinese Medicine Forecasts Swings to 2025 Losses

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"Traditional Chinese Medicine","latestPrice":895.51154,"timestamp":1770710952494,"preClose":893.45544,"halted":0,"volume":38376930,"delay":0,"changeRate":0.002301,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.056091,"latestTime":"02-10 16:00:00","open":893.00397,"high":903.4158,"low":891.96893,"amount":139420203,"amplitude":0.012812,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"pbRate":0.947848,"peRate":15.522774,"turnoverRate":0.002319,"increases":7,"decrements":3,"flats":1,"marketCap":93369949248,"floatMarketCap":63343205952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":903.4158,"amplitude":0.012812,"preClose":893.45544,"low":891.96893,"pbRate":"0.947848","latestPrice":895.51154,"volume":38376930,"delay":0,"open":893.00397,"prevYearClose":830.6915,"prevWeekClose":884.47,"prevMonthClose":878.602,"prevQuarterClose":830.692,"fiveDayClose":869.185,"twentyDayClose":880.578,"sixtyDayClose":906.775,"secType":"PLATE","market":"HK","turnoverRate":0.002319,"peRate":15.522774,"marketCap":93369949248,"floatMarketCap":63343205952,"timestamp":1770710952494,"nameCN":"Traditional Chinese Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":7,"down":3,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610653669","title":"AK Medical Holdings Wins Multiple Hospital Equipment Tenders in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653669","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653669?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:16","pubTimestamp":1770642999,"startTime":"0","endTime":"0","summary":"AK Medical Holdings Ltd. has announced that its wholly-owned subsidiary, Beijing Yidian Lingdong Technology Co., Ltd., has successfully won the tender for the orthopedic hip surgery navigation system and other equipment at The First Affiliated Hospital, Zhejiang University School of Medicine. In addition, the Group has been awarded several tenders during December 2024 and January 2026. Notable awards include Shandong Provincial Hospital , Qingdao Hospital of Traditional Chinese Medicine  , and Peking University Third Hospital . For The First Affiliated Hospital, Zhejiang University School of Medicine, the contract value is RMB 3,980,000 . Revenue from these contracts is expected to be recognized in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3t0VSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","BK1515","00570","BK1606","BK1191","BK1585","BK1100","BK1583","BK1617"],"gpt_icon":0},{"id":"2610763140","title":"Modern Chinese Medicine Group Delays Circular Despatch to April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610763140","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610763140?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:03","pubTimestamp":1770634994,"startTime":"0","endTime":"0","summary":"Modern Chinese Medicine Group Co. Ltd. announced a delay in the despatch of its circular related to a major transaction, originally expected by 9 February 2026. The delay is due to additional time needed to finalize the consolidated audited report of the Target Group for the three years ended 31 December 2025. The company now expects to send the circular on or before 30 April 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL5yJkNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01643","BK1606"],"gpt_icon":0},{"id":"1135852485","title":"Xiao Yaoxi Appointed as Independent Non-Executive Director at Tong Ren Tang Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=1135852485","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135852485?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:50","pubTimestamp":1770367826,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies (01666) announced that Mr. Xiao Yaoxi has been appointed as an independent non-executive director of the company's ninth board of directors, effective February 6, 2026. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK1583","01666","BK1606"],"gpt_icon":0},{"id":"2609563742","title":"Tong Ren Tang Technologies Files Director List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563742","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563742?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:43","pubTimestamp":1770367383,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board is chaired by Executive Director Zhang Yi, who also leads the Nomination Committee and the Strategy and Planning Committee. Other executive directors include Zhang Chun You, the General Manager, and Wen Kai Ting. Non-executive directors are Du Xin and Feng Li. Independent non-executive directors are Chan Ching Har, Eliza, Zhan Yuan Jing, and Siu, Paul Yu Hay. Zhu Dong Sheng serves as Employee Director. Committee memberships are as follows: The Audit Committee is chaired by Siu, Paul Yu Hay, with Chan Ching Har, Eliza and Zhan Yuan Jing as members. The Nomination Committee is chaired by Zhang Yi, joined by Chan Ching Har, Eliza and Zhan Yuan Jing. The Remuneration Committee is chaired by Zhan Yuan Jing, with Chan Ching Har, Eliza and Siu, Paul Yu Hay as members. The Strategy and Planning Committee is chaired by Zhang Yi, with Zhang Chun You, Chan Ching ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6SsjfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","MLKN","BK1515","BK0188","BK1191","BK0239","BK0113","BK0097","BK0012","BK0183","LU1688375341.USD","BK0196","BK0028","BK0086","BK4143","01666","600085","BK1606"],"gpt_icon":0},{"id":"2609563223","title":"Tong Ren Tang Technologies Co. Ltd. Held Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563223?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:41","pubTimestamp":1770367273,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. held an extraordinary general meeting on February 6, 2026. During the meeting, proposals regarding the change of directors and changes in the composition of board committees were considered and approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6459KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0086","BK0113","BK0028","BK0188","BK1583","LU1688375341.USD","01666","BK1606","BK1515","BK0183","BK1191","BK0097","600085","BK0239","BK0196","BK0012"],"gpt_icon":0},{"id":"1195396548","title":"Eight Government Bodies Issue Plan to Boost Traditional Chinese Medicine Industry Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1195396548","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195396548?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:28","pubTimestamp":1770334126,"startTime":"0","endTime":"0","summary":"A new implementation plan for the high-quality development of the traditional Chinese medicine (TCM) industry from 2026 to 2030 has been jointly released by eight departments, including the Ministry...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"61e6c8ace5b151c621bdfbd75522ce8e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","BK1521","00874","BK4588","BK1515","03613","BK1606","VT","BK1191","00570","BK1197","02273","VXUS","BK4585"],"gpt_icon":0},{"id":"1167837170","title":"JPMorgan Boosts Stake in Baiyunshan by 360,600 Shares at HK$18.85 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1167837170","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167837170?lang=en_us&edition=fundamental","pubTime":"2026-02-04 19:18","pubTimestamp":1770203930,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, JPMorgan increased its holding in Baiyunshan (00874) by 360,600 shares on January 30, at a price of HK$18.8482 per share, involving a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","BK1515","LU2592432038.USD","LU1551013342.USD","LU1084165304.USD","LU0203345920.USD","LU0868494617.USD","LU1894683264.USD","BK4207","LU1496350502.SGD","IE00BJTD4N35.SGD","LU1668664300.SGD","IE00BJTD4V19.USD","LU1720051017.SGD","LU0417517546.SGD","BK0239","LU0106831901.USD","LU1629891620.HKD","BK4588","IE00B3S45H60.SGD","IE0034235295.USD","LU0496365809.HKD","LU1244550221.USD","IE00BJLML261.HKD","LU0683600562.USD","LU2054465674.USD","LU0345770308.USD","LU1670628061.USD","LU0943347566.SGD","IE00BZ1G4Q59.USD","LU2381873111.SGD","IE00BFXG1179.USD","LU1548497426.USD","LU2756315664.SGD","IE00BHPRN162.USD","LU2756315318.SGD","BK4504","LU2236285917.USD","LU1119994496.HKD","LU2552382215.SGD","LU1162221912.USD","LU2552382132.HKD","LU0265550946.USD","IE000M9KFDE8.USD","IE00B1XK9C88.USD","JPM","LU0868494708.USD","LU0256863811.USD","LU2237443382.USD","LU2023250330.USD","LU2746668461.USD","BK1606","LU0345769128.USD","BK1197","LU0310799852.SGD","LU1244550577.SGD","LU0048584097.USD","LU1720051108.HKD","600332","BK0012","IE0034235303.USD","LU0251132253.USD","LU0820562030.AUD","LU0070302665.USD","LU1988902786.USD","IE0034235188.USD","LU0265550359.USD","LU2746668974.SGD","IE00BDRTCR15.USD","BK0028","LU1914381329.SGD","LU2237443549.SGD","IE00B1BXHZ80.USD","BK4550","LU1145028129.USD","LU2242649171.HKD","LU0211326839.USD","BK4585","IE00B775SV38.USD","BK0183","IE00BYXW3230.USD","LU0238689110.USD","LU1064131342.USD","LU0320765646.SGD","LU0170899867.USD","LU1366192091.USD","LU1917777945.USD","LU0267386448.USD","LU1894683348.USD","LU2456880835.USD","LU2462157665.USD","LU2505996509.AUD","LU1261432733.SGD","LU1244550494.USD","LU1670627923.USD","BK0188","LU1116320901.HKD","LU2430703178.SGD","LU2237443895.HKD","BK0096","LU2211815571.USD","LU0640476718.USD","LU2430703251.USD","BK0175","LU0320765489.SGD","LU0820561909.HKD","LU2023250843.SGD","LU1363072403.SGD","IE00BKDWB100.SGD","LU2237443622.USD","LU2264538146.SGD","LU1032466523.USD","BK4533","LU1551013425.SGD","LU2213496289.HKD","LU0345770993.USD","LU0149725797.USD","LU0689472784.USD","LU2357305700.SGD","LU0787776722.HKD","LU0211328371.USD","00874","LU0976567544.SGD","LU0882574139.USD","BK4581","LU1116320737.USD","IE00BDCRKT87.USD","LU0234572021.USD","LU0208291251.USD","LU2430703095.HKD","LU2552382058.USD","LU1280957306.USD","SG9999002232.USD","BK4534","LU0211327993.USD","LU0211326755.USD","BK4516","BK1521","LU0106261372.USD","IE00BLSP4452.SGD","LU2417539215.USD","LU2505996681.GBP","BK0070","LU2023250504.SGD","IE00BKVL7J92.USD","LU2106854487.HKD","LU0345769631.USD","BK0196","LU2237443465.HKD","IE00BBT3K403.USD","LU2237443978.SGD","LU0820561818.USD","LU0964807845.USD","LU0203347892.USD","IE00BN8TJ469.HKD","LU0006306889.USD","LU0215105999.USD","IE00BLSP4239.USD","SG9999002224.SGD","IE00BWXC8680.SGD","BK1191","LU1496350171.SGD","LU1267930490.SGD","BK4566","LU0971096721.USD","LU0942090050.USD","LU0323591593.USD","BK0097","LU0211331839.USD"],"gpt_icon":0},{"id":"2608184939","title":"Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules","url":"https://stock-news.laohu8.com/highlight/detail?id=2608184939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608184939?lang=en_us&edition=fundamental","pubTime":"2026-02-03 13:08","pubTimestamp":1770095334,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical's  unit, Guangzhou Baiyunshan Qixing Pharmaceutical, obtained a drug production license from the Guangdong Provincial Drug Administration to become the producer of Xuhanting Granules, according to a Shanghai bourse filing on Tuesday.The granules will be produced at the pharmaceutical company's general plant in Guangzhou, China.The license is valid until July 9, 2030.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","BK0070","BK1191","BK1515","BK0239","BK0012","BK0097","BK0196","BK0175","BK1197","BK0096","BK1606","BK0183","00874","BK0188","BK0028","600332"],"gpt_icon":0},{"id":"1115292752","title":"Baiyunshan (00874): Subsidiary's Pharmaceutical Production License Amended","url":"https://stock-news.laohu8.com/highlight/detail?id=1115292752","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115292752?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:42","pubTimestamp":1770032535,"startTime":"0","endTime":"0","summary":"Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd., has received a Pharmaceutical Production License approved and issued by the Guangdong...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","BK1191","BK1515","BK1521","BK0239","BK0175","BK0097","BK0012","BK0183","BK0096","BK0196","BK0028","BK0070","00874","BK0188","BK1606","600332"],"gpt_icon":0},{"id":"2608850032","title":"China Traditional Chinese Medicine Holdings Co. Limited Held Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608850032?lang=en_us&edition=fundamental","pubTime":"2026-02-02 18:43","pubTimestamp":1770029028,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited held an extraordinary general meeting on 2 February 2026. At the meeting, shareholders approved the Master Supply  Agreement, including the transactions and annual caps for the three years ending 31 December 2028. All proposals put forward at the meeting were duly passed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL4zb4PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00570","BK1515","BK1606"],"gpt_icon":0},{"id":"2608831918","title":"JBM Healthcare CEO to Step Down; Successor Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2608831918","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608831918?lang=en_us&edition=fundamental","pubTime":"2026-02-02 12:08","pubTimestamp":1770005290,"startTime":"0","endTime":"0","summary":"JBM   said chief executive officer Wong Yat Wai, Patrick, will resign, with effect from April 30, to pursue other career opportunities, according to a Jan. 30 Hong Kong bourse filing.Shares of the drug company were down more than 1% in Monday's late morning trade.The company said executive director and chairman Derek Sum Kwong Yip will be appointed chief executive on the same date.Sum has more than 38 years of strategic and corporate management experience in the pharmaceutical industry, and is also chairman and chief executive officer of Jacobson Pharma , the filing showed.Following the change, Sum will serve as both chairman and chief executive.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02161","LU0128526141.USD","BK4137","BK4581","LU0029874061.USD","02633","BK1191","BK4585","XLV","XBI","BK1606","LABU","HCSG","BK4588"],"gpt_icon":0},{"id":"2607075121","title":"Consun Pharmaceutical Group (SEHK:1681) Valuation Check After Expanded HK$300 Million Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2607075121","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607075121?lang=en_us&edition=fundamental","pubTime":"2026-01-31 10:25","pubTimestamp":1769826359,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group expands buyback plan\nConsun Pharmaceutical Group (SEHK:1681) has expanded its existing share repurchase plan, adding HK$100 million to the programme to allow for up to HK$300 million in potential buybacks funded from existing cash resources.\nSee our latest analysis for Consun Pharmaceutical Group.\nThe increased buyback plan comes after a strong run in the shares, with a 15.54% 1 month share price return and a 20.23% 3 month share price return helping support a very...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-valuation-check-after-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-valuation-check-after-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01681","DCF","BK1191","BK1606"],"gpt_icon":0},{"id":"1127394024","title":"JBM HEALTHCARE (02161): Cen Guangye to be Appointed as New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1127394024","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127394024?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:12","pubTimestamp":1769782332,"startTime":"0","endTime":"0","summary":"JBM HEALTHCARE (02161) announced that Mr. Huang Yiwei will resign from his position as the company's Chief Executive Officer to pursue other career development opportunities, effective April 30,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","02161"],"gpt_icon":0},{"id":"2607704939","title":"JBM (Healthcare) Ltd. Appoints Sum Kwong Yip as New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704939","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607704939?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:06","pubTimestamp":1769782003,"startTime":"0","endTime":"0","summary":"JBM  Ltd. has announced that Mr. Wong Yat Wai, Patrick will resign as Chief Executive Officer effective 30 April 2026. Mr. Sum Kwong Yip, Derek, currently serving as Chairman, will be appointed as the new CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBM  Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL6ccsNZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1191","02161"],"gpt_icon":0},{"id":"2607504939","title":"JBM (Healthcare) Ltd - Wong Yat Wai, Patrick Resign as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2607504939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607504939?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:06","pubTimestamp":1769781985,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","02161"],"gpt_icon":0},{"id":"1123581115","title":"CONSUN PHARMA (01681) Proposes to Repurchase Up to HK$300 Million in Company Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1123581115","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123581115?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:50","pubTimestamp":1769676637,"startTime":"0","endTime":"0","summary":"CONSUN PHARMA (01681) announced that on June 13, 2025, the Board of Directors resolved to implement a share repurchase plan, authorizing the buyback of shares on the open market at appropriate times...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2607049877","title":"Consun Pharma Expands Share Buyback Program to HK$300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049877","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049877?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:47","pubTimestamp":1769676460,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical  said it will expand its on-market share repurchase program to an aggregate cap of HK$300 million, following a board resolution, according to a Thursday Hong Kong bourse filing.The company had previously approved a HK$200 million buyback in June 2025 and has now authorised a further HK$100 million under the existing shareholder-approved general mandate.Consun said the repurchases will be funded from existing cash resources and conducted in the open market.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2607701256","title":"Consun Pharmaceutical - Implement Another Share Repurchase Program Increased up to Further HKD100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607701256","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607701256?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:37","pubTimestamp":1769675839,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU03V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"1177101928","title":"Morgan Stanley Cuts TRAD CHI MED (00570) Target Price to HK$1.4, Maintains \"Underweight\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1177101928","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177101928?lang=en_us&edition=fundamental","pubTime":"2026-01-28 15:28","pubTimestamp":1769585308,"startTime":"0","endTime":"0","summary":"According to a research report, Morgan Stanley has updated its risk-return assessment for TRAD CHI MED (00570). Following the company's preliminary 2025 results announcement, and based on...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","00570","BK1606"],"gpt_icon":0},{"id":"2606769239","title":"China Traditional Chinese Medicine Forecasts Swings to 2025 Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2606769239","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606769239?lang=en_us&edition=fundamental","pubTime":"2026-01-28 12:41","pubTimestamp":1769575312,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine  said it expects to swing to a loss in 2025, according to a Hong Kong bourse filing Tuesday.Shares of the medicine firm fell nearly 4% in late morning trade Wednesday.The firm expects a loss of 350 million yuan to 500 million yuan for 2024, compared with a profit of 20.8 million yuan in 2024.The company's financial results are expected by the end of March.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00570","BK1606","BK1515","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}